Jeanne M. Brashear
Patent Agent
Clients seeking advice in establishing and maintaining patent portfolios worldwide in all areas of biotechnology and pharmaceuticals can benefit from the education and experience of Jeanne M. Brashear. As a patent agent, she is involved in all areas of patent prosecution including the drafting and prosecution of patent applications worldwide, patent validity and freedom-to-operate issues and counseling clients concerning competitor patent landscapes. Ms. Brashear works closely with clients in order to obtain patent protection commensurate with commercialization goals.
Recent Client Work
- Successfully drafted and secured patents relating to antibodies and their medical uses for client’s leading biotechnology company.
- Assisted client in developing a patent portfolio directed to angiogenic and lymphangiogenic growth factors, antagonists thereof and medical uses of such therapeutic compounds. The portfolio resulted in the formation of a start-up company focusing on anti-angiogenic technologies. Ms. Brashear continues to assist the start-up company in such matters.
Jeanne M. Brashear
Patent Agent
Clients seeking advice in establishing and maintaining patent portfolios worldwide in all areas of biotechnology and pharmaceuticals can benefit from the education and experience of Jeanne M. Brashear. As a patent agent, she is involved in all areas of patent prosecution including the drafting and prosecution of patent applications worldwide, patent validity and freedom-to-operate issues and counseling clients concerning competitor patent landscapes. Ms. Brashear works closely with clients in order to obtain patent protection commensurate with commercialization goals.
- T.312.474.6639
- F.312.474.0448


Recent Client Work
- Successfully drafted and secured patents relating to antibodies and their medical uses for client’s leading biotechnology company.
- Assisted client in developing a patent portfolio directed to angiogenic and lymphangiogenic growth factors, antagonists thereof and medical uses of such therapeutic compounds. The portfolio resulted in the formation of a start-up company focusing on anti-angiogenic technologies. Ms. Brashear continues to assist the start-up company in such matters.


